Sana Biotechnology, Inc. (SANA)
NASDAQ: SANA · Real-Time Price · USD
4.210
-0.060 (-1.41%)
At close: Feb 27, 2026, 4:00 PM EST
4.130
-0.080 (-1.90%)
After-hours: Feb 27, 2026, 7:51 PM EST
Sana Biotechnology Market Cap
Sana Biotechnology has a market cap or net worth of $1.12 billion as of February 27, 2026. Its market cap has increased by 76.85% in one year.
Market Cap
1.12B
Enterprise Value
1.06B
1-Year Change
76.85%
Ranking
Category
Stock Price
$4.21
Market Cap Chart
Since the IPO on February 4, 2021, Sana Biotechnology's market cap has decreased from $1.33B to $1.12B, a decrease of -15.37%. That is a compound annual growth rate of -3.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 1.12B | 3.44% |
| Dec 31, 2025 | 1.08B | 197.89% |
| Dec 31, 2024 | 363.93M | -54.75% |
| Dec 29, 2023 | 804.30M | 7.21% |
| Dec 30, 2022 | 750.19M | -73.52% |
| Dec 31, 2021 | 2.83B | 113.84% |
| Feb 4, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Inhibrx Biosciences | 1.12B |
| Pharming Group | 1.12B |
| Day One Biopharmaceuticals | 1.09B |
| Geron | 1.07B |
| Bicara Therapeutics | 1.06B |
| AbCellera Biologics | 1.04B |
| Aktis Oncology | 1.03B |
| Compass Therapeutics | 1.02B |